View in EDS

Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.

Saved in:

Bibliographic Details
Title:	Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
Authors:	Mariner-Llicer, Carla¹, Cervera, Belén Saavedra^2,3, Mambuque, Edson³, Gomes, Neide³, Munguambe, Shilzia³, Villamayor, Luis⁴, Cancino-Muñoz, Irving^4,5, Torres-Puente, Manuela¹, Nguenha, Dinis^3,6, Respeito, Durval³, Tembe, Gustavo³, López, Mariana G¹ mglopez@ibv.csic.es, Comas, Iñaki^1,7 icomas@ibv.csic.es, García-Basteiro, Alberto L^2,3,8
Source:	Clinical Infectious Diseases. 4/15/2024, Vol. 78 Issue 4, p842-845. 4p.
Database:	Environment Complete

Description
ISSN:	10584838
DOI:	10.1093/cid/ciad684